Nephros Inc (NEPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 14,162 | 14,238 | 9,975 | 10,217 | 8,561 |
| Cost of Goods | 5,439 | 5,833 | 5,244 | 4,584 | 3,648 |
| Gross Profit | 8,723 | 8,405 | 4,731 | 5,633 | 4,913 |
| Operating Expenses | 9,156 | 10,831 | 9,310 | 9,469 | 9,836 |
| Operating Income | 6 | -1,593 | -4,335 | -3,252 | -4,275 |
| Interest Expense | 1 | 2 | 20 | 41 | 110 |
| Other Income | 84 | 20 | 78 | 509 | -141 |
| Pre-tax Income | 89 | -1,575 | -4,277 | -2,784 | -4,526 |
| Income Tax | 15 | N/A | N/A | N/A | N/A |
| Net Income Continuous | 74 | -1,575 | -4,277 | -2,784 | -4,526 |
| Net Income Discontinuous | N/A | N/A | -2,829 | -1,083 | N/A |
| Minority Interests | N/A | N/A | 276 | 240 | 240 |
| Net Income | $74 | $-1,575 | $-7,382 | $-4,107 | $-4,766 |
| EPS Basic Total Ops | 0.01 | -0.15 | -0.73 | -0.41 | -0.52 |
| EPS Basic Continuous Ops | 0.01 | -0.15 | -0.45 | -0.30 | -0.50 |
| EPS Basic Discontinuous Ops | N/A | N/A | -0.28 | -0.11 | N/A |
| EPS Diluted Total Ops | 0.01 | -0.15 | -0.73 | -0.41 | -0.52 |
| EPS Diluted Continuous Ops | 0.01 | -0.15 | -0.45 | -0.30 | -0.50 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -0.28 | -0.11 | N/A |
| EPS Diluted Before Non-Recurring Items | 0.01 | -0.15 | -0.45 | -0.41 | -0.52 |
| EBITDA(a) | $143 | $-1,379 | $-3,984 | $-3,000 | $-4,067 |